These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2718479)

  • 1. Effects of magnesium citrate and clidinium bromide on the excretion of activated charcoal in normal subjects.
    Vuignier BI; Oderda GM; Gorman RL; Klein-Schwartz W; Watson WA
    DICP; 1989 Jan; 23(1):26-9. PubMed ID: 2718479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of saline cathartics on gastrointestinal transit time of activated charcoal.
    Orisakwe OE; Ogbonna E
    Hum Exp Toxicol; 1993 Sep; 12(5):403-5. PubMed ID: 7902117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of prokinetics on the gastrointestinal transit and residence times of activated charcoal.
    Orisakwe OE; Afonne OJ; Ilondu NA; Obi E; Ufearo CS; Agbasi PU; Maduka SO; Orish CN; Orish VN
    J Pak Med Assoc; 2002 Aug; 52(8):354-6. PubMed ID: 12481675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal transit times of cathartics combined with charcoal.
    Krenzelok EP; Keller R; Stewart RD
    Ann Emerg Med; 1985 Dec; 14(12):1152-5. PubMed ID: 4061985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of purgatives on antidotal efficacy of oral activated charcoal.
    Neuvonen PJ; Olkkola KT
    Hum Toxicol; 1986 Jul; 5(4):255-63. PubMed ID: 3733116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of magnesium citrate cathartic in pediatric toxic ingestions.
    Sue YJ; Woolf A; Shannon M
    Ann Emerg Med; 1994 Oct; 24(4):709-12. PubMed ID: 8092599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of magnesium citrate on the adsorptive capacity of activated charcoal for sodium salicylate.
    Cooney DO; Wijaya J
    Vet Hum Toxicol; 1986 Dec; 28(6):521-3. PubMed ID: 3788030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans.
    Easom JM; Caraccio TR; Lovejoy FH
    Clin Pharm; 1982; 1(2):154-6. PubMed ID: 7185512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saline cathartics and the adsorptive capacity of activated charcoal for aspirin.
    Czajka PA; Konrad JD
    Ann Emerg Med; 1986 May; 15(5):548-51. PubMed ID: 3963535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnesium toxicity secondary to catharsis during management of theophylline poisoning.
    Garrelts JC; Watson WA; Holloway KD; Sweet DE
    Am J Emerg Med; 1989 Jan; 7(1):34-7. PubMed ID: 2914046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of cathartics in pediatric ingestions.
    James LP; Nichols MH; King WD
    Pediatrics; 1995 Aug; 96(2 Pt 1):235-8. PubMed ID: 7630676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal transit times of cathartics used with activated charcoal.
    Krenzelok EP
    Clin Pharm; 1985; 4(4):446-8. PubMed ID: 4042559
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypermagnesemia. A potential complication during treatment of theophylline intoxication with oral activated charcoal and magnesium-containing cathartics.
    Weber CA; Santiago RM
    Chest; 1989 Jan; 95(1):56-9. PubMed ID: 2909356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of magnesium citrate on the in vitro adsorption of aspirin by activated charcoal.
    Lapierre G; Algozzine G; Doering PL
    Clin Toxicol; 1981 Jul; 18(7):793-6. PubMed ID: 7307462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of activated charcoal and magnesium citrate in the treatment of oral paraquat intoxication.
    Gaudreault P; Friedman PA; Lovejoy FH
    Ann Emerg Med; 1985 Feb; 14(2):123-5. PubMed ID: 3970396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathartic-induced magnesium toxicity during overdose management.
    Jones J; Heiselman D; Dougherty J; Eddy A
    Ann Emerg Med; 1986 Oct; 15(10):1214-8. PubMed ID: 3752654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The determination of a degradation product in clidinium bromide drug substance by capillary electrophoresis with indirect UV detection.
    Nickerson B
    J Pharm Biomed Anal; 1997 Apr; 15(7):965-71. PubMed ID: 9160263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose.
    Curtis RA; Barone J; Giacona N
    Arch Intern Med; 1984 Jan; 144(1):48-52. PubMed ID: 6140906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saline cathartics and adsorptive capacity of activated charcoal for doxycycline.
    Afonne OJ; Orisakwe OE; Ofuefule SI; Tsalha S; Obi E; Ilondu NA; Okorie O
    Acta Pol Pharm; 2002; 59(3):177-9. PubMed ID: 12230243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adsorptive capacity of activated charcoal for rifampicin with and without sodium chloride and sodium citrate.
    Orisakwe OE; Afonne OJ; Agbasi PU; Ilondu NA; Ofoefule SI; Obi E
    Biol Pharm Bull; 2001 Jun; 24(6):724-6. PubMed ID: 11411570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.